AACR Presents Third Annual Margaret Foti Award to Anna D. Barker, Ph.D.
April 14, 2008
DENVER - The 3rd Annual American Association for Cancer Research Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research will be presented to Anna D. Barker, Ph.D., deputy director of the National Cancer Institute (NCI).
This award recognizes an individual whose leadership and extraordinary achievements in cancer research, or in support of cancer research, have made a major impact on the field.
"Dr. Barker is a visionary in the field of cancer research," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the American Association for Cancer Research. "She is an unwavering advocate for the adoption of new technologies and increased federal funding for cancer research."
Barker was selected for her exemplary commitment to cancer research, specifically for her promotion of advanced technologies and incorporating new scientific disciplines such as cancer genomics, nanotechnology, bioinformatics and the physical sciences. In addition, before joining the NCI, she led national efforts on behalf of the AACR and other cancer organizations to increase federal funding for research. During her career, Barker has demonstrated innovative leadership in supporting and building partnerships between cancer survivors and patient advocates and cancer researchers.
"Driven by advanced technologies and a convergence of the molecular sciences with the physical sciences, we are unraveling the complexity of cancer at levels that will increasingly enable cancer biologists and oncologists to discover and the private sector to develop a new generation of cancer treatments, diagnostics and preventives ," said Barker.
Under Barker's leadership, the NCI launched new programs in bioinformatics, nanotechnology (Nanotechnology Alliance for Cancer), genomics (The Cancer Genome Atlas), proteomics, biospecimen science and the recent transdisciplinary Physical Sciences-Oncology Centers to enable cancer research.
Barker is also known for her leadership in cancer research advocacy. Of particular note is her position as co-chairperson of THE MARCH - Coming Together to Conquer Cancer Research Task Force, an unprecedented grassroots movement and historical national event, which sought to detail the scientific rationale and need for a significant, immediate increase in the nation's investment in cancer research.
Barker has served in several capacities for the AACR, including as a member of the board of directors and chairperson of the Public Science Policy and Legislative Affairs Committee for 10 years. She was also responsible for establishing the AACR Scientist↔Survivor Program in 1999 and remains actively involved with this innovative program today. Barker has been a member of the AACR since 1978.
Barker completed her doctorate at Ohio State University, where she trained in immunology and microbiology. Her research interests include experimental therapeutics, tumor immunology and free-radical biochemistry in cancer etiology, prevention and treatment. She has received many awards for her unique and stellar contributions to the ongoing national effort to prevent and cure cancer from professional and advocacy organizations, including a named fellowship in basic cancer research from the AACR.
The AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research will be presented at the AACR 100th Annual Meeting 2009 on Sunday, April 19 during the opening ceremony, beginning at 8:15 a.m. MST.
# # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes more than 28,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and nearly 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.
In Denver April 18-22: